The findings suggest targeting cholesterol metabolism as adjuvant therapy for platinum-based chemotherapy in breast cancer. The study was published as a preprint and has not yet been peer reviewed.
First Look
Atorvastatin Improves Cisplatin Sensitivity in Breast Cancer Cells
